Andrejs Braun
Queen Mary University of London Barts and The London School of Medicine and Dentistry
4 papers found
Refreshing results…
Rituximab and obinutuzumab differentially hijack the B-cell receptor and NOTCH1 signaling pathways.
Download from doi.orgLamin B1 regulates somatic mutations and progression of B-cell malignancies
Download from www.nature.comMissing publications? Search for publications with a matching author name.